These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 22253453

  • 1. Targeting myocardial substrate metabolism in heart failure: potential for new therapies.
    Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, Cleland JG, Maggioni A, Fonarow GC, Abel ED, Campia U, Gheorghiade M.
    Eur J Heart Fail; 2012 Feb; 14(2):120-9. PubMed ID: 22253453
    [Abstract] [Full Text] [Related]

  • 2. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A, Milner K, Gupta A, Lopaschuk GD.
    Curr Pharm Des; 2015 Feb; 21(25):3654-64. PubMed ID: 26166604
    [Abstract] [Full Text] [Related]

  • 3. Metabolic support for the heart: complementary therapy for heart failure?
    Heggermont WA, Papageorgiou AP, Heymans S, van Bilsen M.
    Eur J Heart Fail; 2016 Dec; 18(12):1420-1429. PubMed ID: 27813339
    [Abstract] [Full Text] [Related]

  • 4. AMP activated protein kinase-α2 regulates expression of estrogen-related receptor-α, a metabolic transcription factor related to heart failure development.
    Hu X, Xu X, Lu Z, Zhang P, Fassett J, Zhang Y, Xin Y, Hall JL, Viollet B, Bache RJ, Huang Y, Chen Y.
    Hypertension; 2011 Oct; 58(4):696-703. PubMed ID: 21825219
    [Abstract] [Full Text] [Related]

  • 5. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
    Kaimoto S, Hoshino A, Ariyoshi M, Okawa Y, Tateishi S, Ono K, Uchihashi M, Fukai K, Iwai-Kanai E, Matoba S.
    Am J Physiol Heart Circ Physiol; 2017 Feb 01; 312(2):H305-H313. PubMed ID: 28011586
    [Abstract] [Full Text] [Related]

  • 6. Energetics and metabolism in the failing heart: important but poorly understood.
    Turer AT, Malloy CR, Newgard CB, Podgoreanu MV.
    Curr Opin Clin Nutr Metab Care; 2010 Jul 01; 13(4):458-65. PubMed ID: 20453645
    [Abstract] [Full Text] [Related]

  • 7. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.
    Singh KK, Shukla PC, Yanagawa B, Quan A, Lovren F, Pan Y, Wagg CS, Teoh H, Lopaschuk GD, Verma S.
    J Thorac Cardiovasc Surg; 2013 Sep 01; 146(3):702-9. PubMed ID: 23317938
    [Abstract] [Full Text] [Related]

  • 8. The heart metabolism: pathophysiological aspects in ischaemia and heart failure.
    Abozguia K, Shivu GN, Ahmed I, Phan TT, Frenneaux MP.
    Curr Pharm Des; 2009 Sep 01; 15(8):827-35. PubMed ID: 19275646
    [Abstract] [Full Text] [Related]

  • 9. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
    Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD.
    Biochim Biophys Acta; 2011 Jul 01; 1813(7):1333-50. PubMed ID: 21256164
    [Abstract] [Full Text] [Related]

  • 10. Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling.
    Schilling J, Lai L, Sambandam N, Dey CE, Leone TC, Kelly DP.
    Circ Heart Fail; 2011 Jul 01; 4(4):474-82. PubMed ID: 21558447
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting fatty acid metabolism in heart failure: is it a suitable therapeutic approach?
    Arumugam S, Sreedhar R, Thandavarayan RA, Karuppagounder V, Watanabe K.
    Drug Discov Today; 2016 Jun 01; 21(6):1003-8. PubMed ID: 26905600
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
    Okawa Y, Hoshino A, Ariyoshi M, Kaimoto S, Tateishi S, Ono K, Uchihashi M, Iwai-Kanai E, Matoba S.
    Am J Physiol Heart Circ Physiol; 2019 Jun 01; 316(6):H1366-H1377. PubMed ID: 30901275
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure.
    Lopaschuk GD.
    Semin Cardiothorac Vasc Anesth; 2006 Sep 01; 10(3):228-30. PubMed ID: 16959756
    [Abstract] [Full Text] [Related]

  • 20. Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?
    Yurista SR, Chen S, Welsh A, Tang WHW, Nguyen CT.
    Curr Heart Fail Rep; 2022 Aug 01; 19(4):180-190. PubMed ID: 35567658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.